Rhinorrhea Completed Phase 2 Trials for Oxybutynin (DB01062)

Also known as: Nose running / Nasal catarrh / Runny nose / Nasal discharge / Rhinorrhoea

IndicationStatusPhase
DBCOND0020937 (Rhinorrhea)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00816972Desloratadine With Oxybutynin for the Treatment of Seasonal Allergic Rhinitis and Post-Nasal Drip (Study P04258)(COMPLETED)Treatment